Jay Rubin
Neuromusculoskeletal Medicine & OMM · Ocala, FLNPI 1649294448
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations.
Across 40 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$199
- SK Life Science, Inc.$123
- Acadia Pharmaceuticals Inc$103
- AstraZeneca$77
- Eisai Inc.$72
- Lilly USA, LLC$67
- plus $349 from 12 others
Across 920 payments — averaging $7377.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$2.9M
- Biogen$2M
- Novartis$1.2M
- Eli Lilly$457K
- Boehringer Ingelheim$201K
- Boehringer Ingelheim RCV GmbH & Co KG$3K
- plus $636 from 2 others
What the payments were for
- Speaking & faculty fees$485%
- Food & beverage$94295%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $199 |
| SK Life Science, Inc. | 1 | $123 |
| Acadia Pharmaceuticals Inc | 5 | $103 |
| AstraZeneca | 3 | $77 |
| Eisai Inc. | 4 | $72 |
| Lilly USA, LLC | 4 | $67 |
| MDD US Operations, LLC | 3 | $55 |
| Acorda Therapeutics, Inc | 2 | $48 |
| Grifols USA, LLC | 2 | $38 |
| Novartis | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Sunovion Pharmaceuticals Inc. | 3 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| GE HealthCare | 1 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $17 |
| Si-bone, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reveal LINQ$175
- Cenobamate$123
How this compares
$990 in reported general payments places this provider in the 70th percentile of 41 neuromusculoskeletal medicine & omm providers in Florida.
See all neuromusculoskeletal medicine & omm providers in Florida →
Other neuromusculoskeletal medicine & omm in Ocala
- Anthony SancettaOcala$175
- Patricio EspinosaBoca Raton$245K
- Hassan BitarBrandon$12K
- Mohamad SalehTemple Terrace$11K
- Issachar DevineLake Mary$6K
- Ramon Lugo-SanchezMiramar$6K
- Chitto SarkarPort St Lucie$2K
- Glenn ChapmanBoynton Beach$2K
- Jesse KemmerlinSouth Miami$2K
- Jonathan QuinonezRiverview$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.